Skip to main content
. 2017 Mar 20;12(3):e0174024. doi: 10.1371/journal.pone.0174024

Table 3. Antibacterial activity of temporin-SHa analogs compared to the parent peptide.

MIC a, MICGMb (μM)
SHa [K3]SHa [A2,6,9]SHa [A2,6,9, K3]SHa
Gram-negative bacteria
    E. coli ATCC 25922 10 3 > 200 > 200
    E. coli ML-35p 10 3 > 200 > 200
    P. aeruginosa ATCC 27853 50 6 > 200 > 200
    S. entericac 25 6 > 200 > 200
    A. baumannii ATCC 19606 6 3 > 200 > 200
    K. pneumoniae ATCC 13883 12 3 > 200 > 200
14.4 3.8 - -
Gram-positive bacteria
    S. aureus ATCC 25923 3 3 > 200 > 200
    S. aureus ST1065 6 3 > 200 > 200
    S. aureus ATCC 43300d 6 3 - -
    S. aureus ATCC BAA-44e 6 3 - -
    S. pyogenes ATCC 19615 6 1 > 200 100
    L. ivanovii 6 3 > 200 > 200
    E. faecalis ATCC 29212 12 6 > 200 > 200
6 2.8 - -
Yeasts/fungi
    C. albicans ATCC 90028 25 6 > 200 > 200
    C. parapsilosis ATCC 22019 100 25 > 200 > 200
    S. cerevisiae 12 3 > 200 > 200
31.1 7.7 - -

a Values represent the means of three independent experiments performed in triplicate.

b MICGM denotes the geometric mean of the MIC values (indicated in bold) for all Gram-negative, Gram-positive and yeast/fungal strains.

c Serotype Enteritidis.

d Resistant to methicillin and oxacillin.

e Resistant to amoxicillin/clavulanic acid, cephalothin, ciprofloxacin, erythromycin, gentamicin, imipenem, oxacillin, penicillin, tetracycline, ampicillin, doxycycline, methicillin, azithromycin, ceftriaxone, clindamycin, lincomycin, perfloxacin, rifampin, and tobramycin.